Saxend is an FDA-approved prescription injectable medicine that may help some adults with excess weight (body mass index [BMI]≥27) who also have weight-related medical problems or obesity (BMI ≥30), lose weight and keep it off. Saxend should be used with a reduced-calorie meal plan and increased physical activity.

The main ingredient is Liraglutide 3 mg of Saxenda, a GLP-1 analog, a natural hormone that is released in response to eating and acts on the hypothalamus, where it interacts with specific neurons involved in the regulation of appetite and food intake , can make people feel full, suppress appetite, slow down the speed of gastric emptying and then reduce food intake, so as to achieve the effect of weight loss. And with many people having difficulty taking oral medications, Saxenda is a great alternative.

Saxenda has been approved by the Ministry of Health and Welfare of Taiwan, suitable for weight control, as an adjuvant therapy in addition to low-calorie diet and increased physical activity, suitable for adults with an initial body mass index (BMI) ≥ 30 kg/m², or ≥ 27 kg /m² to <30 kg/m² with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or dyslipidemia. The dose must be used step by step according to the doctor's advice, so as not to cause dizziness and nausea discomfort.